A Plasma Metabolic Signature to Diagnose Pulmonary Tuberculosis and Monitor Treatment Response
The Journal of Infectious Diseases · 15.09.2025 · 232 (3) · 578-587
DOI: 10.1093/infdis/jiaf240 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 08.05.2025. Verfasst von Jeffrey M Collins und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Tuberculosis, Pulmonary. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIH National Center for Advancing Translational Science, FIC NIH HHS.
Abstract (Originalsprache)
Background
High-resolution metabolomics has shown promise for identifying blood-based biomarkers of tuberculosis (TB). We sought to discover a metabolic signature to detect pulmonary TB disease and monitor treatment response.
Methods
Plasma from Ethiopian persons with pulmonary TB at diagnosis (n = 82) was compared to household contacts with TB symptoms (n = 104) and 2, 6, and 12 months after treatment initiation. Participants were divided into training and test sets for model building, with additional validation using independent cohorts from the countries of Georgia (n = 89) and South Africa (n = 85). Signatures were further evaluated in nonhuman primates infected with Mycobacterium tuberculosis (Mtb).
Results
Among the metabolites that most significantly differed in concentration, tryptophan (Trp) and retinol were significantly decreased in persons with TB disease (45.2 vs 62.5 μM and 4.1 vs 8.2 μM, respectively), while kynurenine (Kyn) was significantly increased (2.1 vs 1.6 μM; q < .0001 for all). A signature that included the Kyn/Trp ratio and retinol showed excellent classification for TB disease (area under the curve [AUC] = 0.97). The signature had an AUC of 0.97 in HIV-positive and 0.95 in HIV-negative persons with TB disease from South Africa and 0.93 in TB patients from Georgia. In Ethiopian participants, signature scores decreased after 2 months (0.85 to 0.42) and 6 months of TB treatment (0.42 to 0.18; P < .0001 for both) to similar levels as controls. Plasma retinol also declined in nonhuman primates infected with Mtb 15–16 weeks after infection (5.9 vs 3.6 μM; P < .001).
Conclusions
The plasma Kyn/Trp ratio and retinol represents a promising metabolic signature that could advance TB diagnostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
- Armauer Hansen Research Institute, Mycobacterial Diseases Research Directorate, Addis Ababa, Ethiopia.
- Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, Georgia, USA.
- Department of Global Health, Emory University Rollins School of Public Health, Atlanta, Georgia, USA.
- Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA.
- Department of Biostatistics, Emory University Rollins School of Public Health, Atlanta, Georgia, USA.
ORCID-Profile: Jeffrey M Collins, Kidist Bobosha, Cheryl L Day, Russell R Kempker, Max S Y Lau, Nestani Tukvadze, Nazir A Ismail, Joel D Ernst, Liya Wassie
Förderung
- NIAID NIH HHS
- NIH National Center for Advancing Translational Science
- FIC NIH HHS
- National Institute of Allergy and Infectious Diseases
- NCATS NIH HHS
- NIH HHS
- National Institutes of Health
- Fogarty International Center
Zitieren
APA
Collins, J. M., Bobosha, K., Narayanan, N., Gandhi, N. R., Day, C. L., Rengarajan, J., Kempker, R. R., Lau, M. S. Y., Nellis, M., Tukvadze, N., Shah, N. S., Brust, J. C. M., Nizam, A., Ismail, N. A., Kauffman, K. D., Sakai, S., Jones, D. P., Barber, D. L., Ziegler, T. R., …, & Tuberculosis Research Unit - Role of Antigen-Specific T Cell Responses in the Control of TB (TBRU-ASTRa) (2025). A Plasma Metabolic Signature to Diagnose Pulmonary Tuberculosis and Monitor Treatment Response. The Journal of Infectious Diseases, 232(3), 578-587. https://doi.org/10.1093/infdis/jiaf240
Vancouver
Collins JM, Bobosha K, Narayanan N, Gandhi NR, Day CL, Rengarajan J, et al. A Plasma Metabolic Signature to Diagnose Pulmonary Tuberculosis and Monitor Treatment Response. The Journal of Infectious Diseases. 2025;232(3):578-587. doi:10.1093/infdis/jiaf240
BibTeX
@article{Collins2025,
author = {Collins, Jeffrey M and Bobosha, Kidist and Narayanan, Naythra and Gandhi, Neel R and Day, Cheryl L and Rengarajan, Jyothi and Kempker, Russell R and Lau, Max S Y and Nellis, Mary and Tukvadze, Nestani and Shah, N Sarita and Brust, James C M and Nizam, Azhar and Ismail, Nazir A and Kauffman, Keith D and Sakai, Shunsuke and Jones, Dean P and Barber, Daniel L and Ziegler, Thomas R and Ernst, Joel D and Blumberg, Henry M and Wassie, Liya and Tuberculosis Research Unit - Role of Antigen-Specific T Cell Responses in the Control of TB (TBRU-ASTRa), Tuberculosis Research Unit - Role of Antigen-Specific T Cell Responses in the Control of TB (TBRU-ASTRa)},
title = {A Plasma Metabolic Signature to Diagnose Pulmonary Tuberculosis and Monitor Treatment Response},
journal = {The Journal of Infectious Diseases},
year = {2025},
volume = {232},
number = {3},
pages = {578--587},
doi = {10.1093/infdis/jiaf240}
}
EUVIMED